Stock Information

Lineage Cell Therapeutics Inc (LCTX)

Lineage Cell Therapeutics Inc logo
Ticker Symbol: LCTX
Exchange: NYSE
Sector: Biotechnology
Market Cap: $301.73 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -0.2777
Revenue (TTM): $0.06 M
Dividend Yield: N/A%
ROE: -151.35%

Latest News

Key Financials

Financial data not available